SC
RVMDW icon

Sculptor Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Sculptor Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Buy
958,822
+780,715
+438% +$1.51M 0.02% 241
2025
Q4 		$163K Hold
178,107
– – ﹤0.01% 324
2025
Q3 		$50.3K Hold
178,107
– – ﹤0.01% 327
2025
Q2 		$41.8K Hold
178,107
– – ﹤0.01% 338
2025
Q1 		$9.5K Hold
178,107
– – ﹤0.01% 306
2024
Q4 		$30.3K Hold
178,107
– – ﹤0.01% 291
2024
Q3 		$25.8K Hold
178,107
– – ﹤0.01% 281
2024
Q2 		$18.3K Hold
178,107
– – ﹤0.01% 274
2024
Q1 		$33.8K Hold
178,107
– – ﹤0.01% 254
2023
Q4 		$61K Buy
+178,107
New +$79.6K ﹤0.01% 256

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Sculptor Capital's RVMDW Position: Q1 2026 in Review

Sculptor Capital increased its Revolution Medicines Inc Warrant (RVMDW) stake by 438% in Q1 2026, buying an estimated $1.51M and bringing the position to 958,822 shares worth $1.7M. The position accounts for 0.02% of the portfolio, ranked #241.

Sculptor Capital first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Sculptor Capital held 958,822 shares of Revolution Medicines Inc Warrant worth $1.7M as of Q1 2026.
  • Sculptor Capital bought 780,715 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $1.51M.
  • Revolution Medicines Inc Warrant made up 0.02% of Sculptor Capital's portfolio in Q1 2026, its #241 holding.
  • Sculptor Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Sculptor Capital's 13F filing for Q1 2026, filed 15 May 2026.